.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022465

« Back to Dashboard
NDA 022465 describes VOTRIENT, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the VOTRIENT profile page.

The generic ingredient in VOTRIENT is pazopanib hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pazopanib hydrochloride profile page.

Summary for NDA: 022465

Tradename:
VOTRIENT
Applicant:
Novartis Pharms Corp
Ingredient:
pazopanib hydrochloride
Patents:3
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022465

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOTRIENT
pazopanib hydrochloride
TABLET;ORAL 022465 NDA Novartis Pharmaceuticals Corporation 0078-0670 0078-0670-66 120 TABLET, FILM COATED in 1 BOTTLE (0078-0670-66)
VOTRIENT
pazopanib hydrochloride
TABLET;ORAL 022465 NDA GlaxoSmithKline LLC 0173-0804 0173-0804-09 120 TABLET, FILM COATED in 1 BOTTLE (0173-0804-09)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Oct 19, 2009TE:RLD:Yes
Patent:7,105,530Patent Expiration:Oct 19, 2023Product Flag?YSubstance Flag?YDelist Request?
Patent:7,262,203Patent Expiration:Dec 19, 2021Product Flag?YSubstance Flag?YDelist Request?
Patent:8,114,885Patent Expiration:Dec 19, 2021Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc